3 completed, 2 terminated, 1 active not recruiting, 1 unknown. 3 Phase 4, 2 Phase 3, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Active not recruiting 1, Completed 1, Terminated 1 |
| Phase 3 | 2 | Terminated 1, Unknown 1 |
| Not applicable | 1 | Completed 1 |
Follow Clopenthixol: new trials by email Literature Review of Clopenthixol trials Research Report on Clopenthixol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR. Group A: (Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol,anxiolytics: clonazepam, stedon, tavor antidepressants: seropram),, Group B (Pharmacotherapy and TAU) (Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol, clonazepam, stedon, tavor, antidepressants,, Group C (Pharmacotherapy and Psychotherapy) Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol, clonazepam, stedon, tavor, lithium, depakine - Treatment Resistant Schizophrenia, Treatment Resistant Bipolar Disorder | Phase 4 | Active not recruiting | Dr. Stavroula Rakitzi | 84 | 2025-06-04 | 2026-05-01 |
| Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients Olanzapine, Amisulpride, Risperidone - Schizophrenia, Schizophrenia and Disorders With Psychotic Features | Phase 4 | Completed | Technical University of Munich | 21 | 2015-02-01 | 2018-10-11 |
| Pharmacovigilance in Gerontopsychiatric Patients Phenobarbital, Phenytoin, Carbamazepine - Dementia, Depression | Phase 3 | Terminated | Hannover Medical School | 407 | 2015-01-01 | 2018-02-28 |
| Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis Discontinuation antipsychotic treatment, Antipsychotic treatment - Psychosis Nos/Other | Phase 3 | Unknown | Fundación Pública Andaluza Progreso y Salud | 104 | 2012-11-01 | 2014-12-05 |
| Antipsychotics and Risk of Hyperglycemic Emergencies Olanzapine, Risperidone, atypical antipsychotics (other) - Psychotic Disorders, Schizophrenia | Completed | Canadian Network for Observational Drug Effect Studies, CNODES | 725489 | 2012-04-01 | 2015-10-21 | |
| A Study in the Treatment of Acute Mania olanzapine, haloperidol, zuclopentixol - Bipolar Disorder | Phase 4 | Terminated | Eli Lilly and Company | 11 | 2004-10-01 | 2008-10-07 |
| Dopaminergic, Functional, Structural, and Cognitive Disturbances in First-episode Schizophrenia zuclopenthixol, risperidone - Schizophrenia | Not applicable | Completed | Birte Glenthoj | 56 | 1998-01-01 | 2011-09-19 |
Schizophrenia (4) · Bipolar Disorder (2) · Psychotic Disorders (2) · Anxiety Disorders (1) · Cognition Disorders (1) · Dementia (1) · Depression (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Drug-Related Side Effects and Adverse Reactions (1) · Psychophysiologic Disorders (1) · Schizophrenia Spectrum and Other Psychotic Disorders (1) · Schizophrenia, Treatment-Resistant (1)
Birte Glenthoj (1) · Canadian Network for Observational Drug Effect Studies, CNODES (1) · Dr. Stavroula Rakitzi (1) · Eli Lilly and Company (1) · Fundación Pública Andaluza Progreso y Salud (1) · Hannover Medical School (1) · Technical University of Munich (1)
Germany (2) · Canada (1) · Denmark (1) · Greece (1) · Spain (1) · Sweden (1)
Birte Glenthoj, MD, DMSc (1) · Dr. Polyxeni Georgila, M. D. (1) · Dr. Stavroula Rakitzi, PhD (1) · Helge Frieling, Prof., MD (1) · Lorraine Lipscombe, MD, MSc (1) · Markus Dold, MD (1) · Miguel Ruiz Veguilla, MD, PhD (1) · Stefan Leucht, Professor (1)